Skip to main content

Table 1 Clinical and pathological data

From: Pancreatic cancer: Surgery is a feasible therapeutic option for elderly patients

 

All patients

N = 460

<70 years

N = 294

≥70 years

N = 166

P value

Age, years, median (range)

65 (19-87)

55 (19-69)

75 (70-87)

<0.0001

Gender

    

Male (%)

214 (47%)

150 (51%)

64 (39%)

0.01

Female (%)

246 (53%)

144 (49%)

102 (61%)

 

ASA* score

    

1/2

195 (42%)

156 (53%)

39 (24%)

0.002

≥ 3

246 (53%)

126 (43%)

120 (72%)

 

Unknown

19 (5%)

12 (4%)

7 (4%)

 

Second primary cancer (per history)

51 (11%)

25 (9%)

26 (16%)

0.02

Jaundice

160 (35%)

83 (28%)

77 (46%)

<0.0001

Diagnostic evaluation

    

Tomography

443 (96%)

285 (97%)

158 (95%)

0.5

Ultrasound

149 (32%)

99 (34%)

50 (30%)

0.37

Endoscopic ultrasound

291 (63%)

197 (67%)

94 (67%)

0.73

ERCP**

140 (30%)

85 (29%)

55 (33%)

0.21

Preoperative anemia (Hgb < 11 g/dL)

38 (8%)

17 (6%)

21 (13%)

0.12

Tumor site

    

Head

297 (65%)

173 (59%)

124 (73%)

0.004

Body/tail

163 (35%)

121 (41%)

42 (27%)

 

Invasive cancer

293 (64%)

173 (59%)

121 (73%)

0.002

Histology

    

Ductal adenocarcinoma

180 (39%)

105 (36%)

75 (45%)

0.2

Papillary carcinoma

44 (10%)

24 (8%)

20 (12%)

0.41

Cholangiocarcinoma

20 (4%)

14 (5%)

6 (4%)

0.38

IPMN

47(10%)

25 (9%)

22 (13%)

0.16

MCN

53 (12%)

35 (12%)

18 (11%)

0.36

NET

33 (7%)

28 (10%)

5 (3%)

0.009

Others

83 (18%)

63 (20%)

20 (12%)

0.1

  1. * ASA- American society of anesthesiologists; ** ERCP- Endoscopic retrograde cholangiopancreatography